Lung Disease

A new technique will allow researchers to track subsets of immune cells that patrol and defend the lungs, to better understand the roles of these cells during lung inflammation, infection and injury. Read More

Vanderbilt team to focus on engineering, testing the device by Matt Batcheldor Vanderbilt University Medical Center will share in an $8.7 million federal grant to create an artificial lung system that patients with incurable lung disease can use at home. The Department of Defense Congressionally Directed Medical Research Program (CDMRP) grant will fund research to create... Read More

Vanderbilt neonatology team pinpoints signaling pathways involved in the progressive lung fibrosis that occurs in rare genetic diseases. Read More

Vanderbilt researchers have received a National Cancer Institute grant to develop a novel, integrative approach to detect early signs of lung cancer. The four-year project builds on a related, recent study that established the value of using three separate measures—structural imaging, a protein marker and information available from electronic health records—to predict lung cancer in... Read More

Joe G.N. “Skip” Garcia, M.D., recognized for developing novel therapies for critically ill patients with acute inflammatory lung disease, will deliver the next Flexner Discovery Lecture on Thursday, Dec. 10. Read More

Vanderbilt University researchers have found a genetic mutation that causes pulmonary hypertension in cattle grazed at high altitude, and which leads to a life-threatening condition called brisket disease. Read More

Two Vanderbilt University Medical Center investigators recently received awards from the ATS Foundation and its partners to support their lung disease-related research efforts. Read More

Targeting repair pathways in the lung’s air sacs may be a valuable therapeutic direction for pulmonary fibrosis – the scarring of lung tissue. Read More

Vanderbilt’s idiopathic pulmonary fibrosis research group is embarking on a study to determine the prevalence of sleep apnea in people with other interstitial lung diseases. Read More

A new viral protein structure could jump-start vaccine development for two leading causes of lower respiratory disease in children and elderly adults. Read More